Growth Metrics

Gilead Sciences (GILD) Share-based Compensation Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.42%
Dec 31, 2025 7.39%
Sep 30, 2025 5.86%
Jun 30, 2025 9.34%
Mar 31, 2025 8.19%
Dec 31, 2024 7.17%
Sep 30, 2024 5.92%
Jun 30, 2024 3.83%
Mar 31, 2024 5.51%
Dec 31, 2023 2.81%
Sep 30, 2023 0.40%
Jun 30, 2023 -4.71%
Mar 31, 2023 -5.59%
Dec 31, 2022 -12.23%
Sep 30, 2022 8.25%
Jun 30, 2022 10.10%
Mar 31, 2022 7.87%
Dec 31, 2021 9.28%
Sep 30, 2021 12.47%
Jun 30, 2021 11.81%
Mar 31, 2021 9.57%
Dec 31, 2020 10.67%
Sep 30, 2020 12.27%
Jun 30, 2020 8.45%
Mar 31, 2020 8.91%
Dec 31, 2019 10.57%
Sep 30, 2019 10.13%
Jun 30, 2019 15.96%
Mar 31, 2019 11.76%
Dec 31, 2018 19.54%
Sep 30, 2018 25.91%
Jun 30, 2018 35.12%
Mar 31, 2018 28.92%
Dec 31, 2017 42.22%
Sep 30, 2017 15.72%
Jun 30, 2017 16.08%
Mar 31, 2017 12.80%
Dec 31, 2016 16.96%
Sep 30, 2016 15.52%
Jun 30, 2016 13.64%
Mar 31, 2016 12.21%
Dec 31, 2015 12.70%
Sep 30, 2015 13.37%
Jun 30, 2015 14.85%
Mar 31, 2015 14.45%
Dec 31, 2014 17.83%
Sep 30, 2014 18.10%
Jun 30, 2014 15.74%
Mar 31, 2014 14.84%